BRA
LLY icon

Biechele Royce Advisors’s Eli Lilly LLY Stock Holding History

Biechele Royce Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.93M Hold
7,824
– – 2.28% 17
2024
Q2 		$7.08M Sell
7,824
-3
-0% -$2.4K 2.39% 17
2024
Q1 		$6.09M Hold
7,827
– – 2.02% 20
2023
Q4 		$4.56M Hold
7,827
– – 1.49% 21
2023
Q3 		$4.2M Buy
7,827
+39
+0.5% +$20.1K 1.55% 21
2023
Q2 		$3.65M Sell
7,788
-438
-5% -$184K 1.27% 23
2023
Q1 		$2.82M Hold
8,226
– – 1.05% 25
2022
Q4 		$3.01M Buy
8,226
+52
+0.6% +$18.4K 1.23% 25
2022
Q3 		$2.64M Buy
8,174
+65
+0.8% +$20.6K 1.24% 25
2022
Q2 		$2.63M Buy
8,109
+866
+12% +$260K 1.17% 26
2022
Q1 		$2.07M Sell
7,243
-801
-10% -$206K 0.83% 28
2021
Q4 		$2.22M Hold
8,044
– – 0.89% 27
2021
Q3 		$1.86M Buy
8,044
+447
+6% +$110K 0.82% 27
2021
Q2 		$1.74M Hold
7,597
– – 0.76% 28
2021
Q1 		$1.42M Hold
7,597
– – 0.71% 29
2020
Q4 		$1.28M Sell
7,597
-1,219
-14% -$182K 0.72% 28
2020
Q3 		$1.3M Buy
8,816
+80
+0.9% +$12.4K 0.82% 28
2020
Q2 		$1.43M Buy
8,736
+24
+0.3% +$3.68K 0.9% 26
2020
Q1 		$1.21M Hold
8,712
– – 0.93% 26
2019
Q4 		$1.15M Hold
8,712
– – 0.69% 27
2019
Q3 		$974K Sell
8,712
-1,000
-10% -$111K 0.64% 27
2019
Q2 		$1.08M Hold
9,712
– – 0.71% 27
2019
Q1 		$1.26M Hold
9,712
– – 0.82% 28
2018
Q4 		$1.12M Hold
9,712
– – 0.81% 31
2018
Q3 		$1.04M Sell
9,712
-100
-1% -$10K 0.65% 35
2018
Q2 		$837K Hold
9,812
– – 0.56% 37
2018
Q1 		$759K Buy
9,812
+88
+0.9% +$7.08K 0.53% 37
2017
Q4 		$821K Buy
+9,724
New +$827K 0.56% 36

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Biechele Royce Advisors's LLY Position: Q3 2024 in Review

Biechele Royce Advisors held its Eli Lilly (LLY) position steady in Q3 2024 at 7,824 shares worth $6.93M. The position accounts for 2.28% of the portfolio, ranked #17.

Biechele Royce Advisors first reported a position in LLY in Q4 2017 and has held it in 28 quarters since. The position peaked at $7.08M in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Biechele Royce Advisors held 7,824 shares of Eli Lilly worth $6.93M as of Q3 2024.
  • Biechele Royce Advisors left its Eli Lilly share count unchanged in Q3 2024.
  • Eli Lilly made up 2.28% of Biechele Royce Advisors's portfolio in Q3 2024, its #17 holding.
  • Biechele Royce Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 28 quarters since.
  • Biechele Royce Advisors's Eli Lilly position peaked at $7.08M in Q2 2024.
  • 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Biechele Royce Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.